scholarly article | Q13442814 |
P356 | DOI | 10.1177/074873049300800303 |
P698 | PubMed publication ID | 8280909 |
P2093 | author name string | P Lavie | |
O Tzischinsky | |||
A Shlitner | |||
P2860 | cites work | Melatonin shifts human circadian rhythms according to a phase-response curve | Q34253161 |
Different types of melatonin circadian secretory rhythms in some blind subjects | Q34271484 | ||
The importance of timing in melatonin administration in a blind man | Q34311751 | ||
The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod). | Q43752107 | ||
Delayed sleep phase syndrome response to melatonin | Q45274362 | ||
Timing of naps: effects on post-nap sleepiness levels | Q46902469 | ||
Ultrashort sleep-waking schedule. III. 'Gates' and 'forbidden zones' for sleep | Q48353043 | ||
The 24-hour sleep propensity function: experimental bases for somnotypology | Q48884456 | ||
Circadian rhythms in 6-sulphatoxymelatonin and nocturnal sleep in blind children | Q48913950 | ||
Melatonin Administration to Blind People: Phase Advances and Entrainment | Q48914251 | ||
Pineal N-acetyltransferase Activity in Blinded and Anosmic Male Rats12 | Q51120176 | ||
Bioavailability of oral melatonin in humans. | Q52431867 | ||
P433 | issue | 3 | |
P304 | page(s) | 199-209 | |
P577 | publication date | 1993-01-01 | |
P1433 | published in | Journal of Biological Rhythms | Q2093446 |
P1476 | title | The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin | |
P478 | volume | 8 |
Q47685588 | Analysis of Different Melatonin Secretion Patterns in Children With Sleep Disorders: Melatonin Secretion Patterns in Children |
Q34633689 | Assessment of the Potential Role of Tryptophan as the Precursor of Serotonin and Melatonin for the Aged Sleep-wake Cycle and Immune Function: Streptopelia Risoria as a Model. |
Q39190597 | Circadian Disruption Associated with Alzheimer's Disease |
Q37495402 | Circadian sleep-wake rhythm disturbances in end-stage renal disease |
Q21296744 | Clinical uses of melatonin in pediatrics |
Q48747088 | Correlation between the circadian sleep propensity rhythm and hormonal rhythms under ultra-short sleep-wake cycle |
Q25255533 | Daily illumination exposure and melatonin: influence of ophthalmic dysfunction and sleep duration |
Q56506284 | Depression: chronophysiology and chronotherapy |
Q48783990 | Disturbance of sleep in blindness |
Q48778940 | Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs. |
Q34563262 | Effects of exercise with or without light exposure on sleep quality and hormone reponses |
Q41666391 | Efficacy of melatonin as a hypnotic agent |
Q41666388 | Efficacy of melatonin as a sleep-promoting agent |
Q46839791 | Late evening brain activation patterns and their relation to the internal biological time, melatonin, and homeostatic sleep debt |
Q35890534 | Melatonin - a chronobiotic and soporific hormone |
Q47739841 | Melatonin and circadian rhythms in autism: Case report |
Q34970081 | Melatonin and melatonergic drugs on sleep: possible mechanisms of action |
Q41666377 | Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG. |
Q43567911 | Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial |
Q44025868 | Melatonin promotes sleep in three species of diurnal nonhuman primates |
Q43623869 | Melatonin promotes sleep-like state in zebrafish |
Q47999885 | Melatonin, Circadian Rhythms, and Sleep |
Q41666397 | Melatonin: role in gating nocturnal rise in sleep propensity |
Q33936320 | More than a marker: interaction between the circadian regulation of temperature and sleep, age-related changes, and treatment possibilities |
Q28394551 | Morning and Evening Blue-Enriched Light Exposure Alters Metabolic Function in Normal Weight Adults |
Q34324919 | Out of the lab and into the bathroom: evening short-term exposure to conventional light suppresses melatonin and increases alertness perception |
Q48100506 | Pharmacological characterization of M-II, the major human metabolite of ramelteon |
Q33854026 | Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders |
Q48809844 | Potential of Melatonin Replacement Therapy in Older Patients with Sleep Disorders |
Q37004418 | Role of the melatonin system in the control of sleep: therapeutic implications |
Q48717227 | Sleep and circadian phase characteristics of adolescent and young adult males in a naturalistic summertime condition |
Q46636444 | Sleep promoters and insomnia |
Q90342061 | Sleep-wake disturbances in hospitalized patients with traumatic brain injury: association with brain trauma but not with an abnormal melatonin circadian rhythm |
Q36112393 | The effect of traumatic brain injury on the timing of sleep. |
Q37156278 | The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study) |
Q48768493 | The relationship between 6-sulphatoxymelatonin and polysomnographic sleep in good sleeping controls and wake maintenance insomniacs, aged 55-80 years |
Q35023164 | The relationship between the rate of melatonin excretion and sleep consolidation for locomotive engineers in natural sleep settings |
Q38001806 | The role of melatonin in patients with chronic kidney disease undergoing haemodialysis |
Q37217240 | The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders |
Q36448238 | Understanding sleep-wake behavior and sleep disorders in children: the value of a model |
Q37210222 | Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks. |
Q37802476 | What keeps us awake? The role of clocks and hourglasses, light, and melatonin |